Drug rehab can be highly effective for many people, but outcomes depend on program quality, fit, and duration; when weighing options, people often ask about whether rehab appears on a background check as they plan for treatment and employment. Across studies, 30-70% reduce or abstain from use after treatment, and 40-60% relapse in year one, which is comparable to other chronic medical conditions. Completion is pivotal: roughly 43-55% finish treatment, and among completers, 85-95% report abstinence at nine months.
Longer, evidence-based treatment predicts better results. Programs exceeding 90 days, those using medication-assisted treatment for opioid use disorder, and integrated behavioral therapies combined with robust aftercare consistently outperform shorter or single-modality approaches.
Success improves when care matches need, people complete treatment, and aftercare continues. Initial abstinence often reaches 50 to 70 percent. One year outcomes vary by substance, and relapse risk is highest early then falls with time. Medications for opioid use can cut deaths by about half, and mutual help improves continuous abstinence.
Completion predicts outcomes. Inpatient programs average 42 to 70 percent completion, standard outpatient about 50 to 55 percent, and intensive outpatient roughly 60 to 70 percent. Higher retention yields better abstinence at follow up, so use reminder calls, contingency rewards, and flexible scheduling to keep people engaged.
Among those who finish care, abstinence rates at nine months can reach 85 to 95 percent. The key is continuity: complete the full plan, step down to the right intensity, and follow a written aftercare schedule. Combine therapy, peer support, and medications when indicated, and track sleep, cravings, and mood weekly. Keep booster sessions on the calendar.
Outcomes differ by substance. Alcohol shows the most durable gains with structured therapy and community support. Opioid results vary by route, with injection linked to greater risk; medications like buprenorphine or methadone improve survival. Stimulant disorders respond well to contingency management and skills focused relapse prevention.
Risk clusters early. The first 3 to 12 months bring the highest relapse pressure as routines and neurobiology recalibrate. Frequent contacts, skills practice, and medication adherence blunt that risk. After five continuous years, relapse likelihood approaches that of the general population, reflecting stable recovery capital.
Most people do recover. About three in four resolve a substance problem over time, often after several attempts and adjustments in care. Progress accelerates when treatment is matched to need, social supports are strong, and barriers like housing or transport are addressed, allowing health, work, and relationships to rebuild.
Combining adequate duration, indicated medications, and behavioral support yields the best outcomes. For opioid use disorder, retention on methadone or buprenorphine predicts survival and reduces relapse. For alcohol use disorder, FDA-approved medications paired with therapy improve completion and abstinence. Twelve-Step Facilitation and AA participation provide superior continuous abstinence versus several therapies in multiple trials.
Contingency management exerts strong, immediate effects for stimulants, while CBT delivers modest but consistent gains that compound when combined with CM. Integrated treatment that addresses co-occurring mental health and social needs outperforms single-modality care, especially for complex presentations.
Treatment length is one of the strongest predictors of success, with outcomes improving markedly beyond 90 days. Multi-phase care across detox, residential or IOP, outpatient, and recovery housing sustains gains and stabilizes routines. Aftercare that includes peer groups, recovery coaching, medication management, and relapse prevention planning helps convert initial abstinence into durable recovery.
Multiple episodes are common and not a sign of failure. Each episode builds skills and stability; on average, people report about five recovery attempts before sustained remission. Ongoing monitoring and rapid re-engagement after lapses improve long-term prognosis.
Effectiveness reflects an interplay of personal, clinical, and social variables. Engagement, readiness to change, and adherence to medications and appointments are foundational. Clinically, matching care intensity to severity, addressing co-occurring disorders, and maintaining continuity are decisive. Social determinants such as housing, employment, and supportive networks often determine whether gains stick.
Success goes beyond drug testing. Outcomes include reduced use, fewer overdoses, improved mental health, quality of life gains for most people post-completion, employment stability, and decreased criminal justice involvement. Cost-effectiveness analyses show substantial social returns per person helped, supporting investment even when average effect sizes are moderate.
Technology-enabled care and telehealth add consistent access benefits. Post-pandemic flexibilities such as take-home methadone and virtual groups improved retention for many and are increasingly integrated into standard practice.
Rehab outcomes improve when you match care to severity, stick with treatment long enough, and surround yourself with steady support. Start with a full assessment, plan at least ninety days across levels of care, and secure indicated medications. Build routines, accountability, and safe environments that lower stress and make healthy choices easier.
Choose programs that individualize care and use proven methods for your substance and needs. Confirm access to medications for opioid or alcohol use disorders when indicated, and therapies like CBT or Motivational Interviewing. For stimulants, ask about contingency management. Verify that the program tracks outcomes and has strong retention supports.
Design a phased plan of care that spans at least ninety days. Start with medical detox when needed, step into residential or intensive outpatient to stabilize, then transition to standard outpatient with recovery housing or home supports. Longer engagement improves completion and abstinence, while step down models help you keep gains as autonomy grows.
Screen early for depression, anxiety, PTSD, pain, and sleep issues, and treat them alongside the substance use disorder. Coordinated teams align therapy and medications so care feels unified, not fragmented. Addressing these drivers reduces cravings, improves functioning, and lowers dropout by solving the problems that often fuel return to use.
Build a clear aftercare plan before discharge. Schedule weekly groups, peer coaching, and family sessions, and use random testing for accountability. Add telehealth and digital check ins to maintain continuity when life gets busy. Set a specific relapse response plan so you can act quickly and shorten lapses with rapid re entry to the right level of care.
Stabilize the basics that shape everyday behavior. Secure safe housing, reliable transport, and work or school. Choose sober living when home is high risk. Align daily structure with recovery goals, including exercise, regular sleep, and meals. Replace cues that trigger use with new habits, people, and places that support the life you are building.
Invite family or trusted supports into the process and set shared expectations. Family involvement raises completion and satisfaction while easing conflict. Join AA, NA, SMART, or similar groups and attend often. Peer accountability fills the gaps between clinical sessions, builds sober peers, and provides practical help on weekends, nights, and holidays.
Track cravings, mood, sleep, and triggers, then review the data in therapy to guide adjustments. For opioids, maintain adequate buprenorphine or methadone dosing over time. For alcohol, consider naltrexone, acamprosate, or disulfiram with monitoring. Calibrate doses, skills training, and contact frequency so support stays strong when risk is highest.
Studies define success differently, follow-up periods vary, and attrition can skew results. Community settings differ from research cohorts, and publication bias may inflate effects. Even so, the overall signal supports cautious optimism: treatment helps many, and the right mix helps most.
Comparisons across modalities should consider patient matching, retention, and aftercare. Average effects can mask substantial gains for people who receive adequate duration, integrated care, and strong social support; to align expectations with evidence, many people explore how treatment supports recovery from substance use disorders before choosing a program and planning aftercare.
We deliver a private, ultra-luxury addiction treatment and wellness experience in Malibu that balances evidence-based care with holistic therapies, enveloped in discreet, resort-level comfort. Our high staff-to-patient ratio, personalized treatment plans, and serene environment ensure we address psychological, emotional, and physical needs while protecting confidentiality for high-profile clients. From gourmet nutrition and spa services to trauma-informed therapy and advanced fitness, we integrate every detail to accelerate healing and sustain long-term wellness.
We tailor each plan with modalities like CBT, EMDR, and trauma-informed care alongside yoga, mindfulness, acupuncture, cranial sacral work, reiki, sound baths, and aromatherapy. Private suites, chef-driven cuisine, pools, saunas, Jacuzzis, and outdoor spaces support rest and renewal, while personal trainers and nutrition counseling reinforce daily health routines. This seamless blend helps us maintain clients’ lifestyles without compromising clinical rigor or privacy, enabling transformative outcomes that extend beyond sobriety into mental clarity, physical vitality, and emotional resilience.
We offer distinct, high-end residences so you can match your therapeutic goals with the environment that best supports your privacy, routines, and aesthetic. Whether you prefer oceanfront calm, hillside seclusion, or city-adjacent convenience, each house delivers the same clinical excellence, concierge hospitality, and holistic care—differentiated by design, setting, and flow of daily life.
For those who want discreet access to Los Angeles resources without sacrificing sanctuary, this residence balances urban proximity with refined calm. Expect private suites, chef-driven menus, and dedicated therapy spaces that make intensive work feel contained and restorative. Explore the setting, amenities, and experience at The LA Carrara House.
Nestled above the city, this house offers elevated privacy and skyline views ideal for clients who value separation from public life. The layout supports deep therapeutic immersion, mindful practices, and executive-friendly schedules. Learn how the setting supports focused, discreet healing at The Hollywood Hills Carrara House.
Steps from the ocean, this property emphasizes rhythmic, nature-based recovery with sea air, sound, and light as part of the therapeutic container. Oceanfront routines pair with clinical precision for a calm, restorative cadence. See how coastal immersion enhances treatment at The Malibu Beach House.
We invite you to experience a confidential, ultra-luxury path to healing—where personalized clinical care, holistic therapies, and world-class hospitality align to help you recover fully and live well. Take the first step and our team will coordinate a private consultation, outline tailored options across our Malibu, Hollywood Hills, and Los Angeles residences, and craft an admission plan that fits your schedule, goals, and privacy needs.
Britney Elyse has over 15 years experience in mental health and addiction treatment. Britney completed her undergraduate work at San Francisco State University and her M.A. in Clinical Psychology at Antioch University. Britney worked in the music industry for several years prior to discovering her calling as a therapist. Britney’s background in music management, gave her first hand experience working with musicians impacted by addiction. Britney specializes in treating trauma using Somatic Experiencing and evidence based practices. Britney’s work begins with forming a strong therapeutic alliance to gain trust and promote change. Britney has given many presentations on somatic therapy in the treatment setting to increase awareness and decrease the stigma of mental health issues. A few years ago, Britney moved into the role of Clinical Director and found her passion in supervising the clinical team. Britney’s unique approach to client care, allows us to access and heal, our most severe cases with compassion and love. Prior to join the Carrara team, Britney was the Clinical Director of a premier luxury treatment facility with 6 residential houses and an outpatient program